We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.01B
AUM Growth
-$137M
Cap. Flow
-$173M
Cap. Flow %
-17.08%
Top 10 Hldgs %
22.53%
Holding
1,058
New
330
Increased
169
Reduced
200
Closed
293

Sector Composition

Rank Sector Weight
1 Technology 15.55%
2 Communication Services 10.62%
3 Consumer Discretionary 10%
4 Financials 5.08%
5 Healthcare 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOTAR
751
DELISTED
Tottenham Acquisition I Limited Right expiring 3/6/2021
TOTAR
$37K ﹤0.01%
+100,000
New +$38.4K
SOS
752
SOS Limited
SOS
$17.3M
$35K ﹤0.01%
+2
New +$33.4K
DARE icon
753
Dare Bioscience
DARE
$18.6M
$34K ﹤0.01%
2,946
GERN icon
754
Geron
GERN
$860M
$30K ﹤0.01%
+17,085
New +$74.5K
BCACR
755
DELISTED
Bison Capital Acquistion Corp Rights
BCACR
$26K ﹤0.01%
50,120
HOV icon
756
Hovnanian Enterprises
HOV
$758M
$23K ﹤0.01%
584
-168
-22% -$6.81K
NSPR icon
757
InspireMD
NSPR
$31.5M
$22K ﹤0.01%
133
-150
-53% -$23.8K
RAD
758
DELISTED
Rite Aid Corporation
RAD
$21K ﹤0.01%
+805
New +$24.8K
ATXS
759
DELISTED
Astria Therapeutics
ATXS
$18K ﹤0.01%
+380
New +$17.1K
OCGN icon
760
Ocugen
OCGN
$427M
$16K ﹤0.01%
+499
New +$57.8K
PDSB icon
761
PDS Biotechnology
PDSB
$39.1M
$16K ﹤0.01%
+984
New +$17.7K
IMUX icon
762
Immunic
IMUX
$191M
$3K ﹤0.01%
+27
New +$70.5K
A icon
763
Agilent Technologies
A
$39.2B
-3,700
Closed -$229K
ABBV icon
764
PUT
AbbVie
ABBV
$455B
-200
Closed -$1.85M
ABUS icon
765
Arbutus Biopharma
ABUS
$871M
-48,000
Closed -$350K
ACCO icon
766
Acco Brands
ACCO
$390M
-15,079
Closed -$209K
ACRS icon
767
CALL
Aclaris Therapeutics
ACRS
$743M
-495
Closed -$989K
ACRS icon
768
PUT
Aclaris Therapeutics
ACRS
$743M
-158
Closed -$316K
ADI icon
769
Analog Devices
ADI
$179B
-10,948
Closed -$1.05M
ADM icon
770
Archer Daniels Midland
ADM
$38.9B
-5,817
Closed -$267K
ADNT icon
771
Adient
ADNT
$1.72B
-4,177
Closed -$205K
ADP icon
772
Automatic Data Processing
ADP
$105B
-1,925
Closed -$258K
ALL icon
773
Allstate
ALL
$68.3B
-2,429
Closed -$222K
ALNY icon
774
PUT
Alnylam Pharmaceuticals
ALNY
$27.5B
-107
Closed -$1.05M
ALV icon
775
CALL
Autoliv
ALV
$9.09B
-169
Closed -$1.75M

Similar funds

Boothbay Fund Management's Q3 2018 Portfolio in Review

As of Q3 2018, Boothbay Fund Management held 1,058 positions worth $1.01B, down 12% from $1.15B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boothbay Fund Management withdrew a net $173M in Q3 2018, closing 293 positions and reducing 200 holdings. Its most notable exit was XL Group Ltd., an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 11% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Twenty-First Century Fox, Inc. Class B worth $12.7M.

  • Boothbay Fund Management's largest Q3 2018 buy was Twenty-First Century Fox, Inc. Class B: 277,762 shares worth $12.7M.
  • Boothbay Fund Management added most to Dell in Q3 2018, an estimated $9.35M increase.
  • Boothbay Fund Management's biggest Q3 2018 reduction was Netflix, cutting an estimated $27.4M.
  • Boothbay Fund Management fully exited XL Group Ltd. in Q3 2018, selling an estimated $10.2M.
  • Boothbay Fund Management's ten largest holdings make up 23% of its $1.01B portfolio in Q3 2018.
  • Boothbay Fund Management opened 330 new positions and closed 293 in Q3 2018.
  • Boothbay Fund Management's portfolio value fell 12% quarter-over-quarter to $1.01B.

Based on Boothbay Fund Management's 13F filing for Q3 2018, filed 14 Nov 2018.